PetVivo Holdings, Inc. exhibits meaningful progress in its intellectual property portfolio, marked by key patent allowances that could undergird future competitive positioning. However, the company’s historical financials reveal steep revenue declines and sustained net losses, alongside negative operating cash flow, underscoring ongoing difficulties in achieving commercial viability. Liquidity management has pivoted on significant note conversions into equity, adjusting capital structure but reflecting tight cash reserves and leverage risks. Forward growth prospects hinge on successful commercialization of proprietary technology and continued capital adequacy, while disclosed operational risks highlight uncertainties in sustaining business momentum.